CuVerro alloys have been put through rigorous GLP (Good Laboratory Practices) testing by the EPA to evaluate their effectiveness in killing bacteria responsible for many hospital acquired infections (HAIs). The three GLP test protocols used to support EPA registration of antimicrobial copper alloys with public health claims and associated findings:

Wear Test:CuVerro efficacy does not wear out or wear down over time and continues to help inhibit the buildup and growth of bacteria between routine cleaning and sanitizing steps.

Repeated Contamination Test:CuVerro surfaces work continuously to kill more than 99% bacteria, 24 hours a day, even after repeated contamination.

These EPA tests used stainless steel as the control since it represents the most common material used in hospital and surgical settings. The data shows that copper efficacy significantly outperformed stainless steel in all three tests.

Public Health Claims

Based on EPA Registration, products made with CuVerro can be marketed with the following public health claims:

Laboratory testing has shown that when cleaned regularly, this surface: